Borgeson Blake
Transaction: 08/04/2026
SELL
Change
-30,000
Price
$3.25
Filing
08/06/2026
Type
SELL
Recursion Pharmaceuticals, Inc.
RXRX • Biotechnology
$3.63
▲ +0.19 (+5.52%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.93B
Growth
59.0%
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 29.8%Manageable debt level · 0.07Healthy liquidity · 5.5Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$3.63
Change5.52%
Shares Out532.46M
Market Cap$1.93B
Enterprise Value$1.45B
52W Range2.77 - 7.18
Beta1.05
P/E-3.72
P/S35.24
P/B2.11
P/FCF-5.49
EV/Sales26.50
Price$3.63
Change5.52%
Shares Out532.46M
Market Cap$1.93B
Enterprise Value$1.45B
52W Range2.77 - 7.18
Beta1.05
P/E-3.72
P/S35.24
P/B2.11
P/FCF-5.49
EV/Sales26.50
EV/EBITDA-3.07
EV/FCF-4.13
Earnings Yield-26.85%
FCF Yield-18.23%
Dividend Yield0.00%
Gross Margin-61.96%
Oper. Margin-8.68%
Profit Margin-8.63%
Debt/Eq0.07
Current Ratio5.50
Quick Ratio5.50
Revenue 5Y59.02%
Target$5.30
Target Upside46.01%
Target Median$5.30
Target Range5.30 - 5.30
Volume3.11M
Avg Volume20.84M
EPS Surprise0.08
Investment DNA
How strong this company looks for long-term investors
49
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
55/100
Why this score▼
Positive revenue growth · 29.8%Manageable debt level · 0.07Healthy liquidity · 5.5Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 10 analyst votes · 2026-09-05
70/100
Bullish
Bullish
4
Hold
6
Bearish
0
Price Target
2026-08-07
Low
$5.50
Mean
$5.50
Median
$5.50
High
$5.50
Insider Transactions
Recent executive and insider activity
Borgeson Blake
Transaction: 07/07/2026
SELL
Change
-40,000
Price
$3.96
Filing
07/09/2026
Type
SELL
Li Dean Y
Transaction: 07/01/2026
BUY
Change
+3,747
Price
Not reported
Filing
07/02/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Borgeson Blake | SELL | -30,000 | $3.25 | 08/04/2026 | 08/06/2026 |
| Borgeson Blake | SELL | -40,000 | $3.96 | 07/07/2026 | 07/09/2026 |
| Li Dean Y | BUY | +3,747 | Not reported | 07/01/2026 | 07/02/2026 |
| Dar Zavain | BUY | +5,109 | Not reported | 07/01/2026 | 07/02/2026 |
| Bumpus Namandje | SELL | -3,963 | $3.18 | 06/18/2026 | 06/22/2026 |
| Bumpus Namandje | BUY | +88,424 | Not reported | 06/17/2026 | 06/22/2026 |
| Li Dean Y | BUY | +88,424 | Not reported | 06/17/2026 | 06/22/2026 |
| Dar Zavain | BUY | +88,424 | Not reported | 06/17/2026 | 06/22/2026 |
| Sun Elaine D | BUY | +88,424 | Not reported | 06/17/2026 | 06/22/2026 |
| Michor Franziska | BUY | +88,424 | Not reported | 06/17/2026 | 06/22/2026 |
| HERSHBERG ROBERT | BUY | +88,424 | Not reported | 06/17/2026 | 06/22/2026 |
| Borgeson Blake | BUY | +88,424 | Not reported | 06/17/2026 | 06/22/2026 |
| Taylor Ben R | SELL | -5,396 | $3.15 | 06/15/2026 | 06/17/2026 |
| Khan Najat | SELL | -23,588 | $3.58 | 06/05/2026 | 06/05/2026 |
| Gibson Christopher | SELL | -40,000 | $3.62 | 06/05/2026 | 06/05/2026 |
| Gibson Christopher | SELL | -40,000 | Not reported | 06/05/2026 | 06/05/2026 |
| Bumpus Namandje | SELL | -4,386 | $3.54 | 06/03/2026 | 06/04/2026 |
| Borgeson Blake | SELL | -30,000 | $3.68 | 06/02/2026 | 06/04/2026 |
| Gibson Christopher | SELL | -40,000 | $3.08 | 05/22/2026 | 05/27/2026 |
| Gibson Christopher | SELL | -40,000 | Not reported | 05/22/2026 | 05/27/2026 |